ALPINE IMMUNE SCIENCES INC (ALPN)

US02083G1004 - Common Stock

64.62  +0.05 (+0.08%)

After market: 64.62 0 (0%)

Buy % Consensus

87

ChartMill assigns a Buy % Consensus number of 87% to ALPN. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 63.24. This target is -2.14% below the current price.
ALPN was analyzed by 14 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about ALPN.
In the previous month the buy percentage consensus was at a similar level.
ALPN was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 64.6244.4466.3063.2468.25 - -31.23% 2.60% -2.14% 5.62%
Up and Down Grades
Date Firm Action Rating
2024-04-16 TD Cowen Downgrade Buy -> Hold
2024-04-12 Leerink Partners Downgrade Outperform -> Market Perform
2024-04-11 Wolfe Research Downgrade Outperform -> Peer Perform
2024-04-11 RBC Capital Downgrade Outperform -> Sector Perform
2024-04-11 Wedbush Downgrade Outperform -> Neutral
2024-04-11 Morgan Stanley Downgrade Overweight -> Equal-Weight
2024-04-09 Guggenheim Initiate Buy
2024-03-21 HC Wainwright & Co. Maintains Buy -> Buy
2024-03-19 Oppenheimer Reiterate Outperform -> Outperform
2024-03-19 Wedbush Reiterate Outperform -> Outperform
2024-03-19 Morgan Stanley Maintains Overweight -> Overweight
2024-03-19 HC Wainwright & Co. Maintains Buy -> Buy
2024-03-12 RBC Capital Maintains Outperform -> Outperform
2024-02-15 Wolfe Research Initiate Outperform
2024-01-26 Wedbush Maintains Outperform -> Outperform
2023-12-22 HC Wainwright & Co. Maintains Buy -> Buy
2023-11-15 Wedbush Reiterate Outperform -> Outperform
2023-11-03 RBC Capital Maintains Outperform -> Outperform
2023-11-03 Wedbush Maintains Outperform -> Outperform
2023-11-03 Morgan Stanley Maintains Overweight -> Overweight
2023-10-18 Berenberg Initiate Buy
2023-10-05 RBC Capital Initiate Outperform
2023-09-13 HC Wainwright & Co. Reiterate Buy -> Buy
2023-09-11 Oppenheimer Maintains Outperform -> Outperform
2023-09-01 Wedbush Reiterate Outperform -> Outperform
2023-08-31 HC Wainwright & Co. Reiterate Buy -> Buy
2023-08-15 Wedbush Maintains Outperform -> Outperform
2023-08-15 HC Wainwright & Co. Maintains Buy -> Buy
2023-05-12 HC Wainwright & Co. Reiterate Buy -> Buy
2023-03-24 Oppenheimer Reiterate Outperform